-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The first quarter results of chemical giants at a glance
WACKER generated sales of €1.
24 billion in the first quarter of 2019, up 2 percent year-on-year and 4 percent
higher than in the previous quarter.
Earnings before interest, taxes, depreciation and amortization (EBITDA) amounted to €142 million in the first quarter, down 44% year-on-year and 18%
less than in the previous quarter.
Net profit in the first quarter was -6 million euros
.
Total sales in 2019 are forecast to achieve mid-single-digit percentage growth, and EBITDA is expected to be 10%~20%
lower than the previous year.
AkzoNobel achieved first-quarter sales of €2,185 million, adjusted operating income rose 9 percent to €163 million, decorative coatings maintained good growth momentum, and overall earnings rose in the performance coatings business, while automotive coatings and specialty coatings were impacted
by order patterns.
Honeywell's endogenous sales grew 8 percent in the first quarter, reaching $8.
89 billion
.
Driven by the positive impact of business spin-offs, higher volumes and improved operations, the margin was 20.
4%, exceeding 20%
for the second consecutive quarter.
Eastman delivered strong and sustained earnings growth in the first quarter, with sales of $2.
380 billion and EBIT of $320 million, up 28 percent
from the fourth quarter of the previous year.
Solid growth is
expected in the second quarter.
Celanese achieved significant growth
in operating profit and adjusted EBIT in the first quarter.
Net sales in the first quarter reached US$1.
7 billion, down 8.
86% year-on-year; Net profit attributable to ordinary shareholders was US$337 million, down 7.
16%
year-on-year.
The second quarter is expected to be similar to the first quarter
.